Daniella Ferraro Fernandes Costa Pinho MD, Presenter: Nothing to Disclose

Qing Yuan PhD, Abstract Co-Author: Nothing to Disclose

April Alexander Bailey MD, Abstract Co-Author: Nothing to Disclose

Jamie Bolton-Ronacher, Abstract Co-Author: Nothing to Disclose

Brian Andrew Hrycushko PhD, MS, Abstract Co-Author: Nothing to Disclose

Kevin V. Albuquerque MD, Abstract Co-Author: Nothing to Disclose

Ivan Pedrosa MD, Abstract Co-Author: Shareholder, Humana Inc

1. To understand the indications for radiation therapy in cervical cancer and the clinical needs for imaging to provide better treatment planning. 2. To review the safety concerns and technical considerations of pelvic magnetic resonance imaging (MRI) for planning brachytherapy in cervical cancer.  

1. Review of current indications and approach to radiation in cervical cancer patients 2. Limitations of computed tomography to define anatomic boundaries in the pelvis. 3. Advantages of using pelvic MRI to provide better anatomical information for brachytherapy planning. 3. Safety considerations in MRI. a) Conditional applicators vs plastic applicator. b) Specific absorption rate (SAR) limitations. 4. Technical considerations: a) Patient preparation (bladder filling, enema) b) Field strength: 1.5T vs 3T c) MRI protocol: 2D vs 3D T2, diffusion-weighted imaging (DWI) d) Anatomic coverage: key anatomic landmarks. e) CT/MRI fusion 5. Examples of cases with different tumors 6. Conclusion  

http://abstract.rsna.org/uploads/2014/14000331/14000331_o4sl.pdf

Pinho, D, Yuan, Q, Bailey, A, Bolton-Ronacher, J, Hrycushko, B, Albuquerque, K, Pedrosa, I, Pelvic Magnetic Resonance Imaging for Radiation Planning in Cervical Cancer.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14000331.html